Sutro Biopharma Secures $110 Million Through Oversubscribed Equity Offering—What This Means for Their Next-Gen Cancer Portfolio
Market Chameleon (Tue, 10-Feb 9:41 AM)
Sutro Biopharma Advances STRO-004 with First Patients Dosed in Pioneering Phase 1 Study
Market Chameleon (Thu, 4-Dec 10:03 AM)
